Evidence map›Paper›PMID 37959375›Full record

ArticleJournal of clinical medicine2023

Optically Guided High-Frequency Ultrasound to Differentiate High-Risk Basal Cell Carcinoma Subtypes: A Single-Centre Prospective Study.

Szabolcs Bozsányi, Mehdi Boostani, Klára Farkas, Phyllida Hamilton-Meikle, Noémi Nóra Varga, Boglárka Szabó, Flóra Vasanits, Enikő Kuroli, Fanni Adél Meznerics, Kende Lőrincz and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Dermoscopy-guided high-frequency ultrasound: Principles and applications in dermatology.JID innovations : skin science from molecules to population health · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Szabolcs BozsányiDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-1391-419X
Mehdi BoostaniDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0001-9728-1117
Klára FarkasDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-8185-1346
Phyllida Hamilton-MeikleDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Noémi Nóra VargaDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Boglárka SzabóDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Flóra VasanitsDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Enikő KuroliDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Fanni Adél MeznericsDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Kende LőrinczDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-1861-1008
Péter HollóDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
András BánvölgyiDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Norbert M WikonkálDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.
Gyorgy ParaghDepartment of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.ORCID 0000-0002-6612-9267
Norbert KissDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-9947-1755
Semmelweis University · HURoswell Park Comprehensive Cancer Center · US

Funding

EFOP-3.6.3-VEKOP 16-2017-00009ÚNKP 22-2-III-SE-18ÚNKP 23-4-II-SE-8
6 · The paper itself

Abstract

backgroundBasal cell carcinoma (BCC) is the most common type of skin cancer in the Caucasian population. Currently, invasive biopsy is the only way of establishing the histological subtype (HST) that determines the treatment options. Our study aimed to evaluate whether optically guided high-frequency ultrasound (OG-HFUS) imaging could differentiate aggressive HST BCCs from low-risk tumors.

methodsWe conducted prospective clinical and dermoscopic examinations of BCCs, followed by 33 MHz OG-HFUS imaging, surgical excision, and a histological analysis. We enrolled 75 patients with 78 BCCs. In total, 63 BCCs were utilized to establish a novel OG-HFUS risk classification algorithm, while 15 were employed for the validation of this algorithm. The mean age of the patients was 72.9 ± 11.2 years. Histology identified 16 lesions as aggressive HST (infiltrative or micronodular subtypes) and 47 as low-risk HST (superficial or nodular subtypes). To assess the data, we used a one-sided Fisher's exact test for a categorical analysis and a Receiver Operating Characteristic (ROC) curve analysis to evaluate the diagnostic accuracy.

resultsOG-HFUS distinguished aggressive BCC HSTs by their irregular shape (

conclusionsOur study shows that OG-HFUS can identify aggressive BCC HSTs based on easily identifiable morphological parameters, supporting early therapeutic decision making.

Indexed as

aggressive subtypebasal cell carcinomabiopsydermoscopyearly detectionhigh-frequency ultrasoundhistological subtypenon-melanoma skin cancersurgical excision

Identifiers

PMID37959375
PMCPMC10648659
OpenAlexW4388295129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.